MedPath

se of Bio-markers in detection of Early Breast Cancer

Not Applicable
Conditions
Health Condition 1: C00-D49- Neoplasms
Registration Number
CTRI/2023/04/051911
Lead Sponsor
Amrita Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. All patients presented with both benign and malignant breast conditions.

2. All patients who underwent surgical treatment and have not received radiotherapy and/or chemotherapy

Exclusion Criteria

1. Patient aged less than 18 years

2. Males

3. Patients with auto- immune diseases

4. Patients who received chemotherapy or radiotherapy before operation and co- morbid with other malignancies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare Serum miRNA and Histopathological report in Breast disease <br/ ><br>Timepoint: Single pre-operative level at time of first presentation in the Hospital is correlated with post operative histopathology report <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To study the clinical use of Serum miRNA as a tool in early detection of breast cancerTimepoint: Single Pre-operative level at the time of presentation to the hospital
© Copyright 2025. All Rights Reserved by MedPath